The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
Donald S Silverberg, Dov Wexler, Miriam Blum, Gad Keren, David Sheps, Eyal Leibovitch, David Brosh, Shlomo Laniado, Doron Schwartz, Tatyana Yachnin, Itzhak Shapira, Dov Gavish, Ron Baruch, Bella KoifmVolume:
35
Year:
2000
Language:
english
DOI:
10.1016/s0735-1097(00)00613-6
File:
PDF, 157 KB
english, 2000